Trexquant Investment’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Trexquant Investment's ALNY Position: Q3 2026 in Review
Trexquant Investment reduced its Alnylam Pharmaceuticals (ALNY) stake by 93% in Q3 2026, selling an estimated $11.4M and leaving 3,435 shares worth $848K. The position accounts for 0.01% of the portfolio, ranked #1531.
Trexquant Investment first reported a position in ALNY in Q3 2015 and has held it in 23 quarters since. The position peaked at $25M in Q3 2024. 725 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Trexquant Investment held 3,435 shares of Alnylam Pharmaceuticals worth $848K as of Q3 2026.
- Trexquant Investment sold 44,762 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $11.4M.
- Alnylam Pharmaceuticals made up 0.01% of Trexquant Investment's portfolio in Q3 2026, its #1531 holding.
- Trexquant Investment first reported a position in Alnylam Pharmaceuticals in Q3 2015 and has held it in 23 quarters since.
- Trexquant Investment's Alnylam Pharmaceuticals position peaked at $25M in Q3 2024.
- 725 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Trexquant Investment's 13F filing for Q3 2026, filed 16 Nov 2026.